1. Home
  2. KRYS vs CLBT Comparison

KRYS vs CLBT Comparison

Compare KRYS & CLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • CLBT
  • Stock Information
  • Founded
  • KRYS 2015
  • CLBT 1999
  • Country
  • KRYS United States
  • CLBT Israel
  • Employees
  • KRYS N/A
  • CLBT N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • CLBT Computer Software: Prepackaged Software
  • Sector
  • KRYS Health Care
  • CLBT Technology
  • Exchange
  • KRYS Nasdaq
  • CLBT Nasdaq
  • Market Cap
  • KRYS 4.6B
  • CLBT 4.4B
  • IPO Year
  • KRYS 2017
  • CLBT N/A
  • Fundamental
  • Price
  • KRYS $187.96
  • CLBT $19.12
  • Analyst Decision
  • KRYS Strong Buy
  • CLBT Strong Buy
  • Analyst Count
  • KRYS 7
  • CLBT 9
  • Target Price
  • KRYS $210.00
  • CLBT $22.00
  • AVG Volume (30 Days)
  • KRYS 245.3K
  • CLBT 2.4M
  • Earning Date
  • KRYS 02-19-2025
  • CLBT 02-13-2025
  • Dividend Yield
  • KRYS N/A
  • CLBT N/A
  • EPS Growth
  • KRYS 669.23
  • CLBT N/A
  • EPS
  • KRYS 3.00
  • CLBT N/A
  • Revenue
  • KRYS $290,515,000.00
  • CLBT $401,203,000.00
  • Revenue This Year
  • KRYS $483.09
  • CLBT $23.09
  • Revenue Next Year
  • KRYS $57.70
  • CLBT $17.61
  • P/E Ratio
  • KRYS $62.62
  • CLBT N/A
  • Revenue Growth
  • KRYS 473.02
  • CLBT 23.41
  • 52 Week Low
  • KRYS $109.57
  • CLBT $10.25
  • 52 Week High
  • KRYS $219.34
  • CLBT $26.30
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 73.39
  • CLBT 29.83
  • Support Level
  • KRYS $148.00
  • CLBT $18.48
  • Resistance Level
  • KRYS $190.00
  • CLBT $25.03
  • Average True Range (ATR)
  • KRYS 7.31
  • CLBT 1.18
  • MACD
  • KRYS 3.66
  • CLBT -0.77
  • Stochastic Oscillator
  • KRYS 93.87
  • CLBT 8.18

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.

Share on Social Networks: